Ezetimibe reduces cholesterol absorption in the intestines by blocking the Niemann-Pick C1-like-1 protein (NPC1L1), a key transporter on intestinal cell surfaces, which prevents dietary and biliary cholesterol reabsorption and triggers compensatory LDL receptor upregulation on the liver.

factualpending

Speaker

Unknown Speaker (likely MD PhD primary presenter)

Evidence Quote

“Ezetimibe reduces cholesterol absorption in the intestines. Specifically, it blocks something called the Niemann-Pick C1-like-1 protein, a key transporter on the surface of intestinal cells.”

Source

I Tried Statins — Here’s What Happened | Dr Nick Norwitz MD PhD— Nick Norwitz MD PhD
Created: 8/12/2026, 2:28:10 AM

Your notes

Loading notes...